ENT:LSEEntain PLC Analysis
Data as of 2026-06-14 - not real-time
£600.00
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Entain Plc (ENT.L) is trading above its 20‑day and 50‑day moving averages yet still below the 200‑day average, indicating short‑term strength but long‑term weakness. The RSI sits in the mid‑60s and the MACD line sits comfortably above its signal, both pointing to lingering bullish momentum, while a decreasing volume trend and a bearish algorithmic trend flag suggest caution on the near side.
Fundamentally, the company generates strong gross margins and positive free cash flow, but it reports a net loss, an extremely high debt‑to‑equity ratio, and a dividend payout that exceeds earnings, raising sustainability concerns. Analysts are overwhelmingly positive, with a strong‑buy consensus and target prices well above the current level, and a discounted cash‑flow model implies a substantial upside, though the high volatility and regulatory exposure in the gambling sector add considerable risk.
Fundamentally, the company generates strong gross margins and positive free cash flow, but it reports a net loss, an extremely high debt‑to‑equity ratio, and a dividend payout that exceeds earnings, raising sustainability concerns. Analysts are overwhelmingly positive, with a strong‑buy consensus and target prices well above the current level, and a discounted cash‑flow model implies a substantial upside, though the high volatility and regulatory exposure in the gambling sector add considerable risk.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Price near short‑term resistance with bullish MACD but weakening volume
- High short‑term volatility
- Uncertain earnings and dividend sustainability
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- DCF valuation shows significant upside
- Positive free cash flow and strong operating margins
- Analyst consensus and target price upgrades
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Long‑term upside potential versus current price
- Diversified geographic footprint supporting revenue stability
- Potential for debt reduction and margin improvement if regulatory environment remains stable
Key Metrics & Analysis
Financial Health
Revenue Growth3.70%
Profit Margin-12.68%
P/E Ratio8.6
ROE-40.64%
ROA3.44%
Debt/Equity311.21
P/B Ratio4.3
Op. Cash Flow£554.2M
Free Cash Flow£1.0B
Technical Analysis
TrendBearish
RSI63.7
Support£513.60
Resistance£615.60
MA 20£555.71
MA 50£561.15
MA 200£685.33
MACDBullish
VolumeDecreasing
Fear & Greed Index89.86
Valuation
Fair Value£1,926.31
Target Price£943.95
Upside/Downside57.32%
GradeUndervalued
TypeValue
Dividend Yield3.27%
Risk Assessment
Beta0.56
Volatility38.80%
Sector RiskHigh
Reg. RiskHigh
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.